Search

Your search keyword '"Reznichenko, Nataliya"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Reznichenko, Nataliya" Remove constraint Author: "Reznichenko, Nataliya"
21 results on '"Reznichenko, Nataliya"'

Search Results

1. Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

2. A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis

3. Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study

4. Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

6. Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

7. Equity Implications for Mathematics Learning Outcomes

8. Factors That Contribute to the Failure of Developmental Mathematics Courses

9. Learning with Graphing Calculator (GC): GC as a Cognitive Tool

10. Learning Mathematics with Graphing Calculator: A Study of Students' Experiences

11. Design and Study of the Instrument to Assess Students' Attitude toward Graphing Calculator

12. Assessment of Computerized Placement Test for College Mathematics at Baltimore City Community College

13. Implementation of Graphing Calculator in Intermediate Algebra with Function Approach in Community College

14. Randomized, double-blind, multicenter study to evaluate efficacy, safety, tolerability, and immunogenicity between AVT04 and the reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis

15. Randomized, double-blind, multicenter study to evaluate efficacy, safety, tolerability, and immunogenicity between AVT04 and the reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis

16. Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study

17. Learning Intermediate Algebra with Graphing Calculator in Community College: A Study of Graphing Calculator Implementation

19. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial

20. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.

21. Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira ® or undergoing repeated switches between Humira ® and AVT02.

Catalog

Books, media, physical & digital resources